D. E. Shaw & Co., Inc. Cv Rx, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Cv Rx, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 19,319 shares of CVRX stock, worth $201,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,319
Previous 40,273
52.03%
Holding current value
$201,497
Previous $1.27 Million
72.27%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$42.8 Million15.74% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$24.7 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$7.98 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL619KShares$6.45 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$6.2 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $215M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...